Needles & Syringes Sold At Prices 655% More Than The Price At Which Distributors Purchase: NPPA

The Logical Indian Crew

March 7th, 2018 / 12:16 PM

Courtesy: Reporter India | Image Credit: Nocamels.

The National Pharmaceutical Pricing Authority’s (NPPA) analysis has shown that needles and syringes are sold at a retail price which is as much as 655% more than the price at which the distributors purchase them.

The NPPA’s data comes nearly a month after the regulator slashed the prices of cardiac stents by up to 85%.


High markups on needles and syringes

NPPA analysed data from official sources, manufacturers and importers on the trade margins of these products. According to the report, the distributors pay Rs 14.92 for 50 ml hypodermic disposable needles, which are then sold for Rs 65.13. These needles are also the ones to be marked up the most, with 270% trade margin on an average.

The maximum trade margin in case of insulin syringes with needles was at 400%. Depending on the type of syringe, the maximum trade margins may vary between 214% and 1,251%. Whereas the maximum trade margin in disposable hypodermic needles varied from 57% to 789%.

NPPA, in its investigation, had found that Fortis Hospital, Gurugram had charged the parents of a seven-year-old girl who was suffering from dengue a whopping 1,700% markup on medical equipment and drugs in September.

In December last year, syringe and needle makers decided to cap trade margins at 75% after the NPPA found that the companies were charging excessively high prices for drugs and disposables.


High mark ups due to distortion in market

The reason for the high markups is credited to the distortion in markets that occurred few years back. Pavan Choudhary, president of the Medical Technology Association of India, told PTI, “The reason for these markups is that the market got distorted some years ago.Most companies could not sustain without following this trend of high trade margins.

Commenting on the issue, Rajiv Nath, President, All India Syringes & Needle Manufacturers Association (AISNMA) said, “We have studied the trade margin report on syringes and needles by NPPA, and acknowledge the very high trade margins in this product range motivated by an unhealthy race to defend or attain hospital and retailer customers by luring them with higher trade margins than competing brands.


Contributors

Written by : Shraddha Goled

Edited by : Pooja Chaudhuri

Share your thoughts..

Related Stories

Delhi Govt Proposes Law Prohibiting Private Hospitals From Selling Medicines Over 50% Profit

Fortis Hospital Billed Scheduled Drug At 4.4 Times And Consumable At More Than 18 Times The Procurement Price

Trade Deficit

India’s Export Dip In October, Imports Increase, Trade Deficit Widens To Highest In 3 Years

Government Caps Knee Implant Prices By Slashing Rates By Up To 69%

Maximum Retail Price & Market Operating Price

Good To Know: The Difference Between Maximum Retail Price & Market Operating Price

Catheters

Maharashtra FDA Reveals Hospitals Making Extremely High Profits By Selling Catheters 500% Above MRP

Latest on The Logical Indian

News

Maharashtra: Farmers Receive Recovery Notices For Rs 40-50 Lakh Loan Each Which They Never Took

News

With The Killing Of Two Sadhus, Violence Erupted In UP’s Auraiya; Two Policemen Suspended

Environment

This Top Level Drug Scientist Left His High Profile Job In US To Promote Organic Farming In His Village

News

Gauri Lankesh Murder Suspect Confesses To Involvement In Kalburgi Murder Plot

My Story

My Story: “I Was In Deep Sleep When I Felt Weird Sensation,”This Brave Girl Has Message For Those Who Have Suffered Abuse

News

Two Kids Break Piggy Banks To Donate Entire Money For Kerala Relief Fund

x

Stories that deserve attention, delivered to your inbox!

Handpicked, newsworthy stories which deserve the attention of a rational generation.